| |
| Anti-viral Discovery
The Gale Lab is partnering with Kineta, Inc. and the Katze Lab to develop targeted therapeutics to activate innate antiviral defenses in virus infected patients. |
| The Gale Lab is working at the forefront of hepatitis C therapy through efforts to improve the standard of care interferon treatment and through studies aimed at developing agonists of the RIG-I Pathway. |
